CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell 2500 Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | -0.37% | -15.18% | +44.15% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.15% | 298M | |
+10.27% | 9.12B | |
-15.94% | 4.8B | |
+18.47% | 3.72B | |
+1.89% | 3.8B | |
+28.61% | 2.58B | |
-24.63% | 2.36B | |
-29.37% | 2.11B | |
+2.55% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell 2500 Value Index